IncFact
Company Profiles: Revenue, Growth, Competition

I 3 Pharmaceuticals Revenue, Growth & Competitor Profile

Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity

Company Profile & Annual Report for I 3 Pharmaceuticals

Access the complete profile.

I 3 Pharmaceuticals Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
EmployeesN/AExact Company Size
Primary Industry325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
Address200 Park Ave
Warminster, PA 18974

Note: Revenues for privately held companies are statistical evaluations.


I 3 Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • I 3 Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

I 3 Pharmaceuticals Annual Revenue and Growth Rate

I 3 Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $10 - $100 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: I 3 Pharmaceuticals's revenues are gauged from an analysis of company filings.



I 3 Pharmaceuticals's Income Statement (based on Industry Averages)

I 3 Pharmaceuticals P&L$ Millions
Revenue (Sales) I 3 Pharmaceuticals Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Investor Activity

I 3 Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
May 23, 2022 1 100%$16 MM
Complete list of funding rounds and total amounts in the Company Report




Market Share of I 3 Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as I 3 Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
XYMOGENOrlando, FL100 
AVANTI NUTRITIONAL LABORATORIESMiami Lakes, FL37 
NUTRITION FORMULATORSMiramar, FL36 
RTPRCabot, AR33 
INTEGRATED BOTANICSFort Worth, TX29 
COSMAX NBT USAGarland, TX29 
CJB INDUSTRIESValdosta, GA28 
ALTERNATIVE LABORATORIESNaples, FL28 
S&B PHARMAAzusa, CA28 




Nearby Competitors

These companies are similar in business line and location to I 3 Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
PEL HEALTHCARESellersville, PA100 
LAMPIRE BIOLOGICAL LABSPipersville, PA56 
POWDERSIZE LLC DBA MICROSIZEQuakertown, PA35 
I 3 PHARMACEUTICALSWarminster, PA23 
PENN LIFE SCIENCESNewtown, PA13 
EMERGEX USADoylestown, PA12 




Future Competition: I 3 Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as I 3 Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
I 3 Pharmaceuticals Competitors